Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, lactosum monohydricum 32 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.087 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 1.12 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, lactosum monohydricum 96 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.262 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 3.36 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 5 mg, lactosum monohydricum 160 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.437 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 5.6 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

spirig healthcare ag - axitinibum - compresse rivestite con film - axitinibum 7 mg, lactosum monohydricum 224 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.611 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 7.84 mg, e 171, e 172 (rubrum), triacetinum, pro compresso obducto. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 1 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.09 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 33.12 mg. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 3 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.27 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 99.36 mg. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 5 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.46 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 165.60 mg. - carcinoma a cellule renali - synthetika

Sviss - ítalska - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - axitinibum - compresse rivestite con film - axitinibum 7 mg, lactosum monohydricum, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.64 mg, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum, e 171, e 172 (rubrum), triacetinum, pro compresso obducto corresp. lactosum monohydricum 231.84 mg. - carcinoma a cellule renali - synthetika

Ítalía - ítalska - AIFA (Agenzia Italiana del Farmaco)

sandoz s.p.a. - axitinib - axitinib

Evrópusambandið - ítalska - EMA (European Medicines Agency)

pfizer europe ma eeig  - axitinib - carcinoma, cellule renali - inibitori della proteina chinasi - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.